Sunscreen Group Suggests User Fees To Expedite Ingredient Reviews
This article was originally published in The Tan Sheet
Executive Summary
The Public Access to SunScreens Coalition will recommend a user fee program to improve FDA’s work on TEAs for OTC ingredients. “Despite a number of OTC applications waiting for approval for several years, FDA has not completed the review of applications for any new sunscreen components,” PASS says.
You may also be interested in...
FDA Proposal For Increased Sunscreen Safety Testing On NDAC Agenda
FDA’s Nonprescription Drug Advisory Committee will consider proposed tests for evaluating the safety of sunscreen ingredients that sponsors want to add to the OTC monograph. The committee will not consider the safety or efficacy of specific ingredients pending review via TEAs.
FDA Proposal For Increased Sunscreen Safety Testing On NDAC Agenda
FDA’s Nonprescription Drug Advisory Committee will consider proposed tests for evaluating the safety of sunscreen ingredients that sponsors want to add to the OTC monograph. The committee will not consider the safety or efficacy of specific ingredients pending review via TEAs.
Most U.S. Sunscreens Not So Hot, Reflecting FDA Failures – EWG
Sunscreen products earned low marks in EWG’s 2013 guide because FDA’s regulation of the category is not rigorous enough, the group says. But the Personal Care Products Council cautions that consumers may get the wrong message from EWG and choose to not use sunscreen.